485 Results (Page 17 of 20)
China Markets Research Reports
China Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the China infectious disease therapeutics market will reach a value of $15.19 Bn from $9.64 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. Infectious Disease Therapeutics in China is dominated by a few domestic pharmaceutical companies such as WuXi Biologics, Fosun Pharma and CanSino Biologics. The infectious disease therapeutics market in China is segmented into different therapeutic areas and different treatment types. The major factors affecting the China infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of China.
China Clinical Diagnostics Market Analysis
China's clinical diagnostic market was valued at $5.5 Bn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022-30 and will reach $9.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Mindray, Shanghai Fosun Pharmaceutical Group, Guangzhou Wondfo Biotech, Beijing Leadman Biochemistry Co. and others.
China Artificial Intelligence (AI) in Diagnostics Market Analysis
China's Artificial Intelligence (AI) in the Diagnostics market is projected to grow from $0.08 Bn in 2022 to $0.97 Bn by 2030, registering a CAGR of 36.5% during the forecast period of 2022 - 2030. The market will be driven by the growing population and the government's strong support for the development and deployment of AI technology. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Infervision.
China Palliative Care Market Analysis
The China Palliative care market is projected to grow from $1.05 Bn in 2022 to $2.17 Bn by 2030, registering a CAGR of 9.5% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, the rising prevalence of chronic diseases, increasing awareness and government support. The market is segmented by service type and by the end user. Some of the major players include Beijing Haidian Hospital, Fudan University Shanghai Cancer Center, Shanghai Children’s Medical Center and Jigan Temple Community Hospital.
China Robotic Surgery Services Market Analysis
The China Robotic Surgery Service market size was valued at $345 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.8% % from 2022 to 2030 and will reach $1564 Mn in 2030. The robotic surgery service market will grow due to increasing demand for minimally invasive procedures, advancements in technology, and growing prosperity in the country. The market is segmented by product and service type, application type, and end user. Some of the major players are Lingraphica (CHN), Shuanglin Group (CHN), Mirobot (CHN), and others
China Home Healthcare Market Analysis
The China home healthcare market was valued at $29.15 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $59.94 Bn in 2030. One of the main reasons propelling the growth of this market is the rising number of the elderly population and changing lifestyles. The market is segmented by equipment outlook and by services. Some key players in this market are WeDoctor, AliHealth, Haodaifu, JD Health, and iKang Healthcare Group Guahao.
China Rheumatology Drugs Market Analysis
The China Rheumatology Drugs Market is projected to grow from $4.908 Bn in 2022 to $6.873 Bn by 2030, registering a CAGR of 4.30% during the forecast period of 2022-2030. The most commonly used drugs in the treatment of rheumatic diseases include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents. There are a number of domestic pharmaceutical companies in China that are actively involved in the rheumatology drugs market. These companies include China National Biotec Group, Fosun Pharma, and Jiangsu Hengrui Medicine
China Cancer Pain Management Market Analysis
China's Cancer Pain Management market is projected to grow from $524.13 Mn in 2022 to $887.17 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in cancer incidences, growing healthcare expenditure, and an aging population. The market is segmented by drug type and by disease. Some of the major players include Aoxing Pharmaceutical (CHN), Jiangsu Hengrui Medicine (CHN), Hisamitsu Pharmaceutical, Mundipharma, Pfizer, and Teva Pharmaceuticals.
China Orphan Diseases Drugs Market Analysis
The China Orphan Diseases Drugs Market is projected to grow from $12.445 Bn in 2022 to $30.375 Bn by 2030, registering a CAGR of 11.8% during the forecast period of 2022 - 2030. Some of the most common orphan diseases in China include thalassemia, hereditary hearing loss, and primary immunodeficiency diseases. Some of the key players in the China orphan diseases drugs market include Roche, Novartis, Pfizer, Sanofi, AstraZeneca, GlaxoSmithKline, Merck, AbbVie, Johnson & Johnson, and Takeda.
China HIV Therapeutics Market Analysis
By 2030, it is anticipated that the China HIV therapeutics market will reach a value of $1.54 Bn from $1.11 Bn in 2022, growing at a CAGR of 4.2% during 2022-2030. The market is primarily dominated by local players such as Beijing Minhai Biotechnology, Jiangsu Hengrui Medicine, and Sichuan Kelun Pharmaceutical. The market is driven by innovation in research and development, increasing prevalence and reimbursement policies. The HIV therapeutics market in China is segmented by type, product, geography, end user, and distribution channel.
China Women's Health Market Analysis
The China Women’s Health Market is projected to grow from $3.211 Bn in 2022 to $5.234 Bn by 2030, registering a CAGR of 6.30% during the forecast period of 2022 - 2030. The increasing number of working women in China is driving the women's health market as they have more disposable income and need for health care services. Some key players in the China Women's Health market include Peking Union Medical College Hospital and China Women's Health Group.
China Bioinformatics Market Analysis
The China Bioinformatics market is projected to grow from $1.23 Bn in 2022 to $4.58 Bn by 2030, registering a CAGR of 17.80% during the forecast period of 2022 - 2030. The main factors driving the growth are technological advancements and government support. The market is segmented by technology and by application. Some of the major players include BGI Group (CHN), Novogene (CHN), Wuxi NextCODE (CHN), Illumina Inc., Agilent Technologies.
China Breast Cancer Therapeutics Market Analysis
With rising incidences of breast cancer and new technological advancements in breast cancer therapeutics, the China breast cancer therapeutics market is projected to expand from $1.46 Bn in 2022 with a CAGR of 14.4% for the year 2022-2030 to $4.29 Bn in 2030. The China breast cancer market is segmented by therapy, cancer type, and by distribution channel. Shenzhen Main Luck Pharmaceuticals Inc., Bristol-Myers Squibb Co., Eli Lilly, and Co. are some of the key players in the market.
China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
The China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $2.376 Bn in 2022 to $3.702 Bn by 2030, registering a CAGR of 5.70% during the forecast period of 2022 - 2030. The number of individuals diagnosed with ADHD is on the rise in China, leading to a higher demand for ADHD medications. Some of the key players in the China ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market include Novartis, Pfizer, Shire (now part of Takeda), CSPC Pharmaceutical Group, Lanzhou Institute of Biological Products, Huadong Medicine, Hainan Zhongxin Pharmaceutical, Jiangsu Hengrui Medicine, Hunan Erkang Pharmaceutical, Tiantai Pharmaceutical.
China Physiotherapy Market Analysis
The China physiotherapy market size was valued at $4.2 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.35% from 2022 to 2030 and will reach $7.5 Bn in 2030. China physiotherapy market is expected to grow due to several factors, including an aging population, an increase in chronic diseases, and a growing focus on preventative care. The market is segmented by Product Type, Application Type, and End User. The major players in the China physiotherapy market are Mindray Medical International, A. Menarini Diagnostics, Suzhou Acmed Import and Export Co., Shanghai Fosun Long March Medical Science Co, Beijing Choice Electronic Technology Co., Shenzhen Med-Link Electronics Tech Co., and others
China Oncology Drugs Market Analysis
The China oncology drugs market size was valued at $15.79 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.1% from 2022 to 2030 and will reach $42.28 Bn in 2030. The China oncology drug market is segmented by disease, drug type, and end user. The factors driving the oncology drugs market in China are the increasing interest of people in partnerships and trends of research in drugs. A few key players in the oncology drugs market in China are Bio-Thera, I-Mab, Beigene, and Alphamab.
China COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the China COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.
China Growth Hormone Deficiency Clinical Trials Market Analysis
This report presents a strategic analysis of the China Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
China Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of the China Blockchain Technology in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Blockchain Technology in Healthcare Market, offering unmatched value, accuracy and expert insights.
China eHealth Market Analysis
This report presents a strategic analysis of the China eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China eHealth Market, offering unmatched value, accuracy and expert insights.
China ePharmacy Market Analysis
This report presents a strategic analysis of the China ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China ePharmacy Market, offering unmatched value, accuracy and expert insights.
China Sickle Cell Disease Drugs Market Analysis
This report presents a strategic analysis of the China Sickle Cell Disease Drugs Market Analysis and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Sickle Cell Disease Drugs Market Analysis, offering unmatched value, accuracy, and expert insights.
China Dental Care Market Analysis
This report presents a strategic analysis of the China Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Dental Care Market, offering unmatched value, accuracy and expert insights.
China Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the China Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
China Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the China Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Patient Support Programs (PSP) Market, offering unmatched value, accuracy and expert insights.